New-Onset Atrial Fibrillation in Adult Patients After Cardiac Surgery

1.

D’Agostino RS, Jacobs JP, Badhwar V, Fernandez FG, Paone G, Wormuth DW, et al. The Society of Thoracic Surgeons adult cardiac surgery database: 2018 update on outcomes and quality. Ann Thorac Surg. 2018;105(1):15–23. https://doi.org/10.1016/j.athoracsur.2017.10.035.CrossRefPubMed

2.

Shen J, Lall S, Zheng V, Buckley P, Damiano RJ Jr, Schuessler RB. The persistent problem of new-onset postoperative atrial fibrillation: a single-institution experience over two decades. J Thorac Cardiovasc Surg. 2011;141(2):559–70. https://doi.org/10.1016/j.jtcvs.2010.03.011.CrossRefPubMedPubMedCentral

3.

D'Agostino RS, Jacobs JP, Badhwar V, Paone G, Rankin JS, Han JM, et al. The society of thoracic surgeons adult cardiac surgery database: 2016 update on outcomes and quality. Ann Thorac Surg. 2016;101(1):24–32. https://doi.org/10.1016/j.athoracsur.2015.11.032.CrossRefPubMed

4.

Philip I, Berroeta C, Leblanc I. Perioperative challenges of atrial fibrillation. Curr Opin Anaesthesiol. 2014;27(3):344–52. https://doi.org/10.1097/ACO.0000000000000070.CrossRefPubMed

5.

Frendl G, Sodickson AC, Chung MK, Waldo AL, Gersh BJ, Tisdale JE, et al. 2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures. J Thorac Cardiovasc Surg. 2014;148(3):e153–93. https://doi.org/10.1016/j.jtcvs.2014.06.036.CrossRefPubMedPubMedCentral

6.

Almassi GH, Schowalter T, Nicolosi AC, Aggarwal A, Moritz TE, Henderson WG, et al. Atrial fibrillation after cardiac surgery: a major morbid event? Ann Surg. 1997;226(4):501–11 discussion 11-3.CrossRefPubMedPubMedCentral

7.

Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, et al. A multicenter risk index for atrial fibrillation after cardiac surgery. Jama. 2004;291(14):1720–9. https://doi.org/10.1001/jama.291.14.1720.CrossRefPubMed

8.

Kalavrouziotis D, Buth KJ, Ali IS. The impact of new-onset atrial fibrillation on in-hospital mortality following cardiac surgery. Chest. 2007;131(3):833–9. https://doi.org/10.1378/chest.06-0735.CrossRefPubMed

9.

LaPar DJ, Speir AM, Crosby IK, Fonner E Jr, Brown M, Rich JB, et al. Postoperative atrial fibrillation significantly increases mortality, hospital readmission, and hospital costs. Ann Thorac Surg. 2014;98(2):527–33; discussion 33. https://doi.org/10.1016/j.athoracsur.2014.03.039.CrossRefPubMed

10.

Almassi GH, Wagner TH, Carr B, Hattler B, Collins JF, Quin JA, et al. Postoperative atrial fibrillation impacts on costs and one-year clinical outcomes: the Veterans Affairs Randomized On/Off Bypass Trial. Ann Thorac Surg. 2015;99(1):109–14. https://doi.org/10.1016/j.athoracsur.2014.07.035.CrossRefPubMed

11.

Steinberg BA, Zhao Y, He X, Hernandez AF, Fullerton DA, Thomas KL, et al. Management of postoperative atrial fibrillation and subsequent outcomes in contemporary patients undergoing cardiac surgery: insights from the Society of Thoracic Surgeons CAPS-Care Atrial Fibrillation Registry. Clin Cardiol. 2014;37(1):7–13. https://doi.org/10.1002/clc.22230.CrossRefPubMed

12.

Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994;271(11):840–4.CrossRefPubMed

13.

Echahidi N, Pibarot P, O'Hara G, Mathieu P. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol. 2008;51(8):793–801. https://doi.org/10.1016/j.jacc.2007.10.043.CrossRefPubMed

14.

Kim MH, Johnston SS, Chu BC, Dalal MR, Schulman KL. Estimation of total incremental health care costs in patients with atrial fibrillation in the United States. Circ Cardiovasc Qual Outcomes. 2011;4(3):313–20. https://doi.org/10.1161/CIRCOUTCOMES.110.958165.CrossRefPubMed

15.

Wolowacz SE, Samuel M, Brennan VK, Jasso-Mosqueda JG, Van Gelder IC. The cost of illness of atrial fibrillation: a systematic review of the recent literature. Europace. 2011;13(10):1375–85. https://doi.org/10.1093/europace/eur194.CrossRefPubMed

16.

Greenberg JW, Lancaster TS, Schuessler RB, Melby SJ. Postoperative atrial fibrillation following cardiac surgery: a persistent complication. Eur J Cardiothorac Surg. 2017;52(4):665–72. https://doi.org/10.1093/ejcts/ezx039.CrossRefPubMed

17.

Toivonen L, Kadish A, Kou W, Morady F. Determinants of the ventricular rate during atrial fibrillation. J Am Coll Cardiol. 1990;16(5):1194–200.CrossRefPubMed

18.

Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm. 2012;9(4):632–96 e21. https://doi.org/10.1016/j.hrthm.2011.12.016.CrossRefPubMed

19.

Ferrari R, Bertini M, Blomstrom-Lundqvist C, Dobrev D, Kirchhof P, Pappone C, et al. An update on atrial fibrillation in 2014: from pathophysiology to treatment. Int J Cardiol. 2016;203:22–9. https://doi.org/10.1016/j.ijcard.2015.10.089.CrossRefPubMed

20.

Iwasaki YK, Nishida K, Kato T, Nattel S. Atrial fibrillation pathophysiology: implications for management. Circulation. 2011;124(20):2264–74. https://doi.org/10.1161/CIRCULATIONAHA.111.019893.CrossRefPubMed

21.

Chard M, Tabrizchi R. The role of pulmonary veins in atrial fibrillation: a complex yet simple story. Pharmacol Ther. 2009;124(2):207–18. https://doi.org/10.1016/j.pharmthera.2009.07.002.CrossRefPubMed

22.

Vaitkevicius R, Saburkina I, Rysevaite K, Vaitkeviciene I, Pauziene N, Zaliunas R, et al. Nerve supply of the human pulmonary veins: an anatomical study. Heart Rhythm. 2009;6(2):221–8. https://doi.org/10.1016/j.hrthm.2008.10.027.CrossRefPubMed

23.

Nattel S, Burstein B, Dobrev D. Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythm Electrophysiol. 2008;1(1):62–73. https://doi.org/10.1161/CIRCEP.107.754564.CrossRefPubMed

24.

Voigt N, Heijman J, Wang Q, Chiang DY, Li N, Karck M, et al. Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation. Circulation. 2014;129(2):145–56. https://doi.org/10.1161/CIRCULATIONAHA.113.006641.CrossRefPubMed

25.

Tchervenkov CI, Wynands JE, Symes JF, Malcolm ID, Dobell AR, Morin JE. Persistent atrial activity during cardioplegic arrest: a possible factor in the etiology of postoperative supraventricular tachyarrhythmias. Ann Thorac Surg. 1983;36(4):437–43.CrossRefPubMed

26.

Melby SJ, George JF, Picone DJ, Wallace JP, Davies JE, George DJ, et al. A time-related parametric risk factor analysis for postoperative atrial fibrillation after heart surgery. J Thorac Cardiovasc Surg. 2015;149(3):886–92. https://doi.org/10.1016/j.jtcvs.2014.11.032.CrossRefPubMed

27.

Banach M, Rysz J, Drozdz JA, Okonski P, Misztal M, Barylski M, et al. Risk factors of atrial fibrillation following coronary artery bypass grafting: a preliminary report. Circ J. 2006;70(4):438–41.CrossRefPubMed

28.

Wong JK, Lobato RL, Pinesett A, Maxwell BG, Mora-Mangano CT, Perez MV. P-wave characteristics on routine preoperative electrocardiogram improve prediction of new-onset postoperative atrial fibrillation in cardiac surgery. J Cardiothorac Vasc Anesth. 2014;28(6):1497–504. https://doi.org/10.1053/j.jvca.2014.04.034.CrossRefPubMed

29.

Aytemir K, Aksoyek S, Ozer N, Aslamaci S, Oto A. Atrial fibrillation after coronary artery bypass surgery: P wave signal averaged ECG, clinical and angiographic variables in risk assessment. Int J Cardiol. 1999;69(1):49–56.CrossRefPubMed

30.

Amat-Santos IJ, Rodes-Cabau J, Urena M, DeLarochelliere R, Doyle D, Bagur R, et al. Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation. J Am Coll Cardiol. 2012;59(2):178–88. https://doi.org/10.1016/j.jacc.2011.09.061.CrossRefPubMed

31.

Mahoney EM, Thompson TD, Veledar E, Williams J, Weintraub WS. Cost-effectiveness of targeting patients undergoing cardiac surgery for therapy with intravenous amiodarone to prevent atrial fibrillation. J Am Coll Cardiol. 2002;40(4):737–45.CrossRefPubMed

32.

Orlowska-Baranowska E, Baranowski R, Michalek P, Hoffman P, Rywik T, Rawczylska-Englert I. Prediction of paroxysmal atrial fibrillation after aortic valve replacement in patients with aortic stenosis: identification of potential risk factors. J Heart Valve Dis. 2003;12(2):136–41.PubMed

33.

Wiggins MC, Firpi HA, Blanco RR, Amer M, Dudley SC. Prediction of atrial fibrillation following cardiac surgery using rough set derived rules. Conf Proc IEEE Eng Med Biol Soc. 2006;1:4006–9. https://doi.org/10.1109/IEMBS.2006.259834.CrossRefPubMedCentral

34.

Magee MJ, Herbert MA, Dewey TM, Edgerton JR, Ryan WH, Prince S, et al. Atrial fibrillation after coronary artery bypass grafting surgery: development of a predictive risk algorithm. Ann Thorac Surg. 2007;83(5):1707–12; discussion 12. https://doi.org/10.1016/j.athoracsur.2006.12.032.CrossRefPubMed

35.

Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263–72. https://doi.org/10.1378/chest.09-1584.CrossRefPubMed

36.

Silva RG, Lima GG, Guerra N, Bigolin AV, Petersen LC. Risk index proposal to predict atrial fibrillation after cardiac surgery. Rev Bras Cir Cardiovasc. 2010;25(2):183–9.CrossRefPubMed

37.

Karaca M, Demirbas MI, Biceroglu S, Cevik A, Cetin Y, Arpaz M, et al. Prediction of early postoperative atrial fibrillation after cardiac surgery: is it possible? Cardiovasc J Afr. 2012;23(1):34–6. https://doi.org/10.5830/CVJA-2011-010.CrossRefPubMedPubMedCentral

38.

Helgadottir S, Sigurdsson MI, Ingvarsdottir IL, Arnar DO, Gudbjartsson T. Atrial fibrillation following cardiac surgery: risk analysis and long-term survival. J Cardiothorac Surg. 2012;7:87. https://doi.org/10.1186/1749-8090-7-87.CrossRefPubMedPubMedCentral

39.

Chua SK, Shyu KG, Lu MJ, Lien LM, Lin CH, Chao HH, et al. Clinical utility of CHADS2 and CHA2DS2-VASc scoring systems for predicting postoperative atrial fibrillation after cardiac surgery. J Thorac Cardiovasc Surg. 2013;146(4):919–26 e1. https://doi.org/10.1016/j.jtcvs.2013.03.040.CrossRefPubMed

40.

Mariscalco G, Biancari F, Zanobini M, Cottini M, Piffaretti G, Saccocci M, et al. Bedside tool for predicting the risk of postoperative atrial fibrillation after cardiac surgery: the POAF score. J Am Heart Assoc. 2014;3(2):e000752. https://doi.org/10.1161/JAHA.113.000752.CrossRefPubMedPubMedCentral

41.

Borde D, Gandhe U, Hargave N, Pandey K, Mathew M, Joshi S. Prediction of postoperative atrial fibrillation after coronary artery bypass grafting surgery: is CHA 2 DS 2 -VASc score useful? Ann Card Anaesth. 2014;17(3):182–7. https://doi.org/10.4103/0971-9784.135841.CrossRefPubMed

42.

Kolek MJ, Muehlschlegel JD, Bush WS, Parvez B, Murray KT, Stein CM, et al. Genetic and clinical risk prediction model for postoperative atrial fibrillation. Circ Arrhythm Electrophysiol. 2015;8(1):25–31. https://doi.org/10.1161/CIRCEP.114.002300.CrossRefPubMedPubMedCentral

43.

Yin L, Ling X, Zhang Y, Shen H, Min J, Xi W, et al. CHADS2 and CHA2DS2-VASc scoring systems for predicting atrial fibrillation following cardiac valve surgery. PLoS One. 2015;10(4):e0123858. https://doi.org/10.1371/journal.pone.0123858.CrossRefPubMedPubMedCentral

44.

Tran DT, Perry JJ, Dupuis JY, Elmestekawy E, Wells GA. Predicting new-onset postoperative atrial fibrillation in cardiac surgery patients. J Cardiothorac Vasc Anesth. 2015;29(5):1117–26. https://doi.org/10.1053/j.jvca.2014.12.012.CrossRefPubMed

45.

Zhang W, Liu W, Chew ST, Shen L, Ti LK. A clinical prediction model for postcardiac surgery atrial fibrillation in an Asian population. Anesth Analg. 2016;123(2):283–9. https://doi.org/10.1213/ANE.0000000000001384.CrossRefPubMed

46.

Cameron MJ, Tran DTT, Abboud J, Newton EK, Rashidian H, Dupuis JY. Prospective external validation of three preoperative risk scores for prediction of new onset atrial fibrillation after cardiac surgery. Anesth Analg. 2018;126(1):33–8. https://doi.org/10.1213/ANE.0000000000002112.CrossRefPubMed

47.

•• Muehlschlegel JD, Burrage PS, Ngai JY, Prutkin JM, Huang CC, Xu X, et al. Society of Cardiovascular Anesthesiologists/European Association of Cardiothoracic Anaesthetists Practice Advisory for the Management of Perioperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery. Anesth Analg. 2019;128(1):33–42. https://doi.org/10.1213/ANE.0000000000003865Most recent analysis and summation of current multi-society post-cardiac surgery atrial fibrillation guidelines, includes graphical advisory tool. CrossRefPubMed

48.

•• O'Brien B, Burrage PS, Ngai JY, Prutkin JM, Huang CC, Xu X, et al. Society of Cardiovascular Anesthesiologists/European Association of Cardiothoracic Anaesthetists Practice Advisory for the Management of Perioperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery. J Cardiothorac Vasc Anesth. 2019;33(1):12–26. https://doi.org/10.1053/j.jvca.2018.09.039Most recent analysis and summation of current multi-society post-cardiac surgery atrial fibrillation guidelines, includes graphical advisory tool. CrossRefPubMed

49.

•• Arsenault KA, Yusuf AM, Crystal E, Healey JS, Morillo CA, Nair GM et al. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. The Cochrane database of systematic reviews. 2013;(1):Cd003611. doi:https://doi.org/10.1002/14651858.CD003611.pub3. Comprenhensive meta-analysis of efficacy of both pharmacologic and non-pharmacologic interventions on incidence of atrial fibrillation as well as effect on secondary outcomes such as stroke, LOS and cost.

50.

Campbell NG, Allen E, Sanders J, Swinson R, Birch S, Sturgess J, et al. The impact of maintaining serum potassium ≥3.6 mEq/L vs ≥4.5 mEq/L on the incidence of new-onset atrial fibrillation in the first 120 hours after isolated elective coronary artery bypass grafting – study protocol for a randomised feasibility trial for the proposed Tight K randomized non-inferiority trial. Trials. 2017;18(1):618. https://doi.org/10.1186/s13063-017-2349-x.CrossRefPubMedPubMedCentral

51.

Dunning J, Treasure T, Versteegh M, Nashef SA. Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery. Eur J Cardiothorac Surg. 2006;30(6):852–72. https://doi.org/10.1016/j.ejcts.2006.09.003.CrossRefPubMed

52.

Burgess DC, Kilborn MJ, Keech AC. Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. Eur Heart J. 2006;27(23):2846–57. https://doi.org/10.1093/eurheartj/ehl272.CrossRefPubMed

53.

Thein PM, White K, Banker K, Lunny C, Mirzaee S, Nasis A. Preoperative use of oral beta-adrenergic blocking agents and the incidence of new-onset atrial fibrillation after cardiac surgery. A systematic review and meta-analysis. Heart Lung Circ. 2018;27(3):310–21. https://doi.org/10.1016/j.hlc.2017.08.026.CrossRefPubMed

54.

Tamura T, Yatabe T, Yokoyama M. Prevention of atrial fibrillation after cardiac surgery using low-dose landiolol: a systematic review and meta-analysis. J Clin Anesth. 2017;42:1–6. https://doi.org/10.1016/j.jclinane.2017.07.009.CrossRefPubMed

55.

Ji T, Feng C, Sun L, Ye X, Bai Y, Chen Q, et al. Are beta-blockers effective for preventing post-coronary artery bypass grafting atrial fibrillation? Direct and network meta-analyses. Ir J Med Sci. 2016;185(2):503–11. https://doi.org/10.1007/s11845-016-1447-1.CrossRefPubMed

56.

Sakamoto A, Hamasaki T, Kitakaze M. Perioperative landiolol administration reduces atrial fibrillation after cardiac surgery: a meta-analysis of randomized controlled trials. Adv Ther. 2014;31(4):440–50. https://doi.org/10.1007/s12325-014-0116-x.CrossRefPubMedPubMedCentral

57.

Wang HS, Wang ZW, Yin ZT. Carvedilol for prevention of atrial fibrillation after cardiac surgery: a meta-analysis. PLoS One. 2014;9(4):e94005. https://doi.org/10.1371/journal.pone.0094005.CrossRefPubMedPubMedCentral

58.

Liu S, Bian C, Zhang Y, Jian Y, Liu W. Landiolol hydrochloride for prevention of atrial fibrillation after cardiac surgery: a meta-analysis. Pacing Clin Electrophysiol. 2014;37(6):691–6. https://doi.org/10.1111/pace.12379.CrossRefPubMed

59.

Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol. 2011;57(11):e101–98. https://doi.org/10.1016/j.jacc.2010.09.013.CrossRefPubMed

60.

Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Rev Esp Cardiol (Engl Ed). 2017;70(1):50. https://doi.org/10.1016/j.rec.2016.11.033.CrossRef

61.

Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG, et al. Special Articles: 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Anesth Analg. 2012;114(1):11–45. https://doi.org/10.1213/ANE.0b013e3182407c25.CrossRefPubMed

62.

Bagshaw SM, Galbraith PD, Mitchell LB, Sauve R, Exner DV, Ghali WA. Prophylactic amiodarone for prevention of atrial fibrillation after cardiac surgery: a meta-analysis. Ann Thorac Surg. 2006;82(5):1927–37.CrossRefPubMed

63.

Aasbo JD, Lawrence AT, Krishnan K, Kim MH, Trohman RG. Amiodarone prophylaxis reduces major cardiovascular morbidity and length of stay after cardiac surgery: a meta-analysis. Ann Intern Med. 2005;143(5):327–36.CrossRefPubMed

64.

Gillespie EL, Coleman CI, Sander S, Kluger J, Gryskiewicz KA, White CM. Effect of prophylactic amiodarone on clinical and economic outcomes after cardiothoracic surgery: a meta-analysis. Ann Pharmacother. 2005;39(9):1409–15. https://doi.org/10.1345/aph.1E592.CrossRefPubMed

65.

Chatterjee S, Sardar P, Mukherjee D, Lichstein E, Aikat S. Timing and route of amiodarone for prevention of postoperative atrial fibrillation after cardiac surgery: a network regression meta-analysis. Pacing Clin Electrophysiol. 2013;36(8):1017–23. https://doi.org/10.1111/pace.12140.CrossRefPubMed

66.

Zhu J, Wang C, Gao D, Zhang C, Zhang Y, Lu Y, et al. Meta-analysis of amiodarone versus beta-blocker as a prophylactic therapy against atrial fibrillation following cardiac surgery. Intern Med J. 2012;42(10):1078–87. https://doi.org/10.1111/j.1445-5994.2012.02844.x.CrossRefPubMed

67.

Buckley MS, Nolan PE Jr, Slack MK, Tisdale JE, Hilleman DE, Copeland JG. Amiodarone prophylaxis for atrial fibrillation after cardiac surgery: meta-analysis of dose response and timing of initiation. Pharmacotherapy. 2007;27(3):360–8. https://doi.org/10.1592/phco.27.3.360.CrossRefPubMed

68.

Somberg J, Molnar J. Sotalol versus amiodarone in treatment of atrial fibrillation. J Atr Fibrillation. 2016;8(5):1359. https://doi.org/10.4022/jafib.1359.CrossRefPubMedPubMedCentral

69.

Kerin NZ, Jacob S. The efficacy of sotalol in preventing postoperative atrial fibrillation: a meta-analysis. Am J Med. 2011;124(9):875 e1–9. https://doi.org/10.1016/j.amjmed.2011.04.025.CrossRef

70.

Wurdeman RL, Mooss AN, Mohiuddin SM, Lenz TL. Amiodarone vs. sotalol as prophylaxis against atrial fibrillation/flutter after heart surgery: a meta-analysis. Chest. 2002;121(4):1203–10.CrossRefPubMed

71.

Gorenek B, Pelliccia A, Benjamin EJ, Boriani G, Crijns HJ, Fogel RI, et al. European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS). Europace. 2017;19(2):190–225. https://doi.org/10.1093/europace/euw242.CrossRefPubMed

72.

Patel N, Kluger J. Ranolazine for prevention of atrial fibrillation after cardiac surgery: a systematic review. Cureus. 2018;10(5):e2584. https://doi.org/10.7759/cureus.2584.CrossRefPubMedPubMedCentral

73.

Trivedi C, Upadhyay A, Solanki K. Efficacy of ranolazine in preventing atrial fibrillation following cardiac surgery: results from a meta-analysis. J Arrhythm. 2017;33(3):161–6. https://doi.org/10.1016/j.joa.2016.10.563.CrossRefPubMed

74.

Cappabianca G, Rotunno C, de Luca Tupputi Schinosa L, Ranieri VM, Paparella D. Protective effects of steroids in cardiac surgery: a meta-analysis of randomized double-blind trials. J Cardiothorac Vasc Anesth. 2011;25(1):156–65. https://doi.org/10.1053/j.jvca.2010.03.015.CrossRefPubMed

75.

Marik PE, Fromm R. The efficacy and dosage effect of corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a systematic review. J Crit Care. 2009;24(3):458–63. https://doi.org/10.1016/j.jcrc.2008.10.016.CrossRefPubMed

76.

Dvirnik N, Belley-Cote EP, Hanif H, Devereaux PJ, Lamy A, Dieleman JM, et al. Steroids in cardiac surgery: a systematic review and meta-analysis. Br J Anaesth. 2018;120(4):657–67. https://doi.org/10.1016/j.bja.2017.10.025.CrossRefPubMed

77.

Cheruku KK, Ghani A, Ahmad F, Pappas P, Silverman PR, Zelinger A, et al. Efficacy of nonsteroidal anti-inflammatory medications for prevention of atrial fibrillation following coronary artery bypass graft surgery. Prev Cardiol. 2004;7(1):13–8.CrossRefPubMed

78.

Horbach SJ, Lopes RD, da CGJC MF, Mehta RH, Petracco JB, et al. Naproxen as prophylaxis against atrial fibrillation after cardiac surgery: the NAFARM randomized trial. Am J Med. 2011;124(11):1036–42. https://doi.org/10.1016/j.amjmed.2011.07.026.CrossRefPubMed

79.

Papageorgiou N, Briasoulis A, Lazaros G, Imazio M, Tousoulis D. Colchicine for prevention and treatment of cardiac diseases: A meta-analysis. Cardiovasc Ther. 2017;35(1):10–8. https://doi.org/10.1111/1755-5922.12226.CrossRefPubMed

80.

Salih M, Smer A, Charnigo R, Ayan M, Darrat YH, Traina M, et al. Colchicine for prevention of post-cardiac procedure atrial fibrillation: Meta-analysis of randomized controlled trials. Int J Cardiol. 2017;243:258–62. https://doi.org/10.1016/j.ijcard.2017.04.022.CrossRefPubMed

81.

Verma S, Eikelboom JW, Nidorf SM, Al-Omran M, Gupta N, Teoh H, et al. Colchicine in cardiac disease: a systematic review and meta-analysis of randomized controlled trials. BMC Cardiovasc Disord. 2015;15:96. https://doi.org/10.1186/s12872-015-0068-3.CrossRefPubMedPubMedCentral

82.

Trivedi C, Sadadia M. Colchicine in prevention of atrial fibrillation following cardiac surgery: systematic review and meta-analysis. Indian J Pharm. 2014;46(6):590–5. https://doi.org/10.4103/0253-7613.144905.CrossRef

83.

Lennerz C, Barman M, Tantawy M, Sopher M, Whittaker P. Colchicine for primary prevention of atrial fibrillation after open-heart surgery: Systematic review and meta-analysis. Int J Cardiol. 2017;249:127–37. https://doi.org/10.1016/j.ijcard.2017.08.039.CrossRefPubMed

84.

Putzu A, Capelli B, Belletti A, Cassina T, Ferrari E, Gallo M, et al. Perioperative statin therapy in cardiac surgery: a meta-analysis of randomized controlled trials. Crit Care. 2016;20(1):395. https://doi.org/10.1186/s13054-016-1560-6.CrossRefPubMedPubMedCentral

85.

Kuhn EW, Liakopoulos OJ, Stange S, Deppe AC, Slottosch I, Choi YH, et al. Preoperative statin therapy in cardiac surgery: a meta-analysis of 90,000 patients. Eur J Cardiothorac Surg. 2014;45(1):17–26; discussion. https://doi.org/10.1093/ejcts/ezt181.CrossRefPubMed

86.

Zhang B, Zhen Y, Tao A, Bao Z, Zhang G. Polyunsaturated fatty acids for the prevention of atrial fibrillation after cardiac surgery: an updated meta-analysis of randomized controlled trials. J Cardiol. 2014;63(1):53–9. https://doi.org/10.1016/j.jjcc.2013.06.014.CrossRefPubMed

87.

Langlois PL, Hardy G, Manzanares W. Omega-3 polyunsaturated fatty acids in cardiac surgery patients: An updated systematic review and meta-analysis. Clin Nutr. 2017;36(3):737–46. https://doi.org/10.1016/j.clnu.2016.05.013.CrossRefPubMed

88.

Wang H, Chen J, Zhao L. N-3 polyunsaturated fatty acids for prevention of postoperative atrial fibrillation: updated meta-analysis and systematic review. J Interv Card Electrophysiol. 2018;51(2):105–15. https://doi.org/10.1007/s10840-018-0315-5.CrossRefPubMed

89.

Ali-Hasan-Al-Saegh S, Mirhosseini SJ, Tahernejad M, Mahdavi P, Shahidzadeh A, Karimi-Bondarabadi AA, et al. Impact of antioxidant supplementations on cardio-renal protection in cardiac surgery: an updated and comprehensive meta-analysis and systematic review. Cardiovasc Ther. 2016;34(5):360–70. https://doi.org/10.1111/1755-5922.12207.CrossRefPubMed

90.

Mariani J, Doval HC, Nul D, Varini S, Grancelli H, Ferrante D, et al. N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc. 2013;2(1):e005033. https://doi.org/10.1161/JAHA.112.005033.CrossRefPubMedPubMedCentral

91.

Harrison RW, Hasselblad V, Mehta RH, Levin R, Harrington RA, Alexander JH. Effect of levosimendan on survival and adverse events after cardiac surgery: a meta-analysis. J Cardiothorac Vasc Anesth. 2013;27(6):1224–32. https://doi.org/10.1053/j.jvca.2013.03.027.CrossRefPubMed

92.

Wang B, He X, Gong Y, Cheng B. Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery: An Update Meta-Analysis and Trial Sequential Analysis. Biomed Res Int. 2018;2018:7563083. https://doi.org/10.1155/2018/7563083.CrossRefPubMedPubMedCentral

93.

Ali-Hassan-Sayegh S, Mirhosseini SJ, Rezaeisadrabadi M, Dehghan HR, Sedaghat-Hamedani F, Kayvanpour E, et al. Antioxidant supplementations for prevention of atrial fibrillation after cardiac surgery: an updated comprehensive systematic review and meta-analysis of 23 randomized controlled trials. Interact Cardiovasc Thorac Surg. 2014;18(5):646–54. https://doi.org/10.1093/icvts/ivu020.CrossRefPubMed

94.

Liu XH, Xu CY, Fan GH. Efficacy of N-acetylcysteine in preventing atrial fibrillation after cardiac surgery: a meta-analysis of published randomized controlled trials. BMC Cardiovasc Disord. 2014;14:52. https://doi.org/10.1186/1471-2261-14-52.CrossRefPubMedPubMedCentral

95.

Gu WJ, Wu ZJ, Wang PF, Aung LH, Yin RX. N-Acetylcysteine supplementation for the prevention of atrial fibrillation after cardiac surgery: a meta-analysis of eight randomized controlled trials. BMC Cardiovasc Disord. 2012;12:10. https://doi.org/10.1186/1471-2261-12-10.CrossRefPubMedPubMedCentral

96.

Shi R, Li ZH, Chen D, Wu QC, Zhou XL, Tie HT. Sole and combined vitamin C supplementation can prevent postoperative atrial fibrillation after cardiac surgery: a systematic review and meta-analysis of randomized controlled trials. Clin Cardiol. 2018;41(6):871–8. https://doi.org/10.1002/clc.22951.CrossRefPubMedPubMedCentral

97.

Hemila H, Suonsyrja T. Vitamin C for preventing atrial fibrillation in high risk patients: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2017;17(1):49. https://doi.org/10.1186/s12872-017-0478-5.CrossRefPubMedPubMedCentral

98.

Hu X, Yuan L, Wang H, Li C, Cai J, Hu Y, et al. Efficacy and safety of vitamin C for atrial fibrillation after cardiac surgery: a meta-analysis with trial sequential analysis of randomized controlled trials. Int J Surg. 2017;37:58–64. https://doi.org/10.1016/j.ijsu.2016.12.009.CrossRefPubMed

99.

Baker WL, Coleman CI. Meta-analysis of ascorbic acid for prevention of postoperative atrial fibrillation after cardiac surgery. Am J Health Syst Pharm. 2016;73(24):2056–66. https://doi.org/10.2146/ajhp160066.CrossRefPubMed

100.

Hajjar LA, Vincent JL, Barbosa Gomes Galas FR, Rhodes A, Landoni G, Osawa EA, et al. Vasopressin versus Norepinephrine in Patients with Vasoplegic Shock after Cardiac Surgery: The VANCS Randomized Controlled Trial. Anesthesiology. 2017;126(1):85–93. https://doi.org/10.1097/aln.0000000000001434.CrossRefPubMed

101.

Biancari F, Mahar MA. Meta-analysis of randomized trials on the efficacy of posterior pericardiotomy in preventing atrial fibrillation after coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2010;139(5):1158–61. https://doi.org/10.1016/j.jtcvs.2009.07.012.CrossRefPubMed

102.

Hu XL, Chen Y, Zhou ZD, Ying J, Hu YH, Xu GH. Posterior pericardiotomy for the prevention of atrial fibrillation after coronary artery bypass grafting: A meta-analysis of randomized controlled trials. Int J Cardiol. 2016;215:252–6. https://doi.org/10.1016/j.ijcard.2016.04.081.CrossRefPubMed

103.

Cummings JE, Gill I, Akhrass R, Dery M, Biblo LA, Quan KJ. Preservation of the anterior fat pad paradoxically decreases the incidence of postoperative atrial fibrillation in humans. J Am Coll Cardiol. 2004;43(6):994–1000. https://doi.org/10.1016/j.jacc.2003.07.055.CrossRefPubMed

104.

Liu S, Jing Y, Zhang J, Bian C, Zhang YU, Zhang X. Does Anterior Fat Pad Removal Reduce the Incidence of Atrial Fibrillation after CABG? A Meta-Analysis of Randomized Controlled Trials. Pacing Clin Electrophysiol. 2015;38(11):1363–8. https://doi.org/10.1111/pace.12740.CrossRefPubMed

105.

White CM, Sander S, Coleman CI, Gallagher R, Takata H, Humphrey C, et al. Impact of epicardial anterior fat pad retention on postcardiothoracic surgery atrial fibrillation incidence: the AFIST-III Study. J Am Coll Cardiol. 2007;49(3):298–303. https://doi.org/10.1016/j.jacc.2006.10.033.CrossRefPubMed

106.

Pokushalov E, Kozlov B, Romanov A, Strelnikov A, Bayramova S, Sergeevichev D, et al. Botulinum toxin injection in epicardial fat pads can prevent recurrences of atrial fibrillation after cardiac surgery: results of a randomized pilot study. J Am Coll Cardiol. 2014;64(6):628–9. https://doi.org/10.1016/j.jacc.2014.04.062.CrossRefPubMed

107.

Romanov A, Pokushalov E, Ponomarev D, Bayramova S, Shabanov V, Losik D, et al. Long-term suppression of atrial fibrillation by botulinum toxin injection into epicardial fat pads in patients undergoing cardiac surgery: three-year follow-up of a randomized study. Heart Rhythm. 2018. https://doi.org/10.1016/j.hrthm.2018.08.019.

108.

Pokushalov E, Kozlov B, Romanov A, Strelnikov A, Bayramova S, Sergeevichev D, et al. Long-term suppression of atrial fibrillation by botulinum toxin injection into epicardial fat pads in patients undergoing cardiac surgery: one-year follow-up of a randomized pilot study. Circ Arrhythm Electrophysiol. 2015;8(6):1334–41. https://doi.org/10.1161/circep.115.003199.CrossRefPubMed

109.

Waldron NH, Cooter M, Haney JC, Schroder JN, Gaca JG, Lin SS, et al. Temporary autonomic modulation with botulinum toxin type A to reduce atrial fibrillation after cardiac surgery. Heart Rhythm. 2019;16(2):178–184.https://doi.org/10.1016/j.hrthm.2018.08.021.

110.

Moller CH, Penninga L, Wetterslev J, Steinbruchel DA, Gluud C. Off-pump versus on-pump coronary artery bypass grafting for ischaemic heart disease. Cochrane Database Syst Rev. 2012;(3):Cd007224. doi:https://doi.org/10.1002/14651858.CD007224.pub2.

111.

Boning A, Diegeler A, Hilker M, Zacher M, Reents W, Faerber G, et al. Preoperative atrial fibrillation and outcome in patients undergoing on-pump or off-pump coronary bypass surgery: lessons learned from the GOPCABE trial. Interact Cardiovasc Thorac Surg. 2015;20(1):74–8. https://doi.org/10.1093/icvts/ivu331.CrossRefPubMed

112.

Zaman AG, Alamgir F, Richens T, Williams R, Rothman MT, Mills PG. The role of signal averaged P wave duration and serum magnesium as a combined predictor of atrial fibrillation after elective coronary artery bypass surgery. Heart. 1997;77(6):527–31.CrossRefPubMedPubMedCentral

113.

Lomivorotov VV, Efremov SM, Pokushalov EA, Karaskov AM. New-onset atrial fibrillation after cardiac surgery: pathophysiology, prophylaxis, and treatment. J Cardiothorac Vasc Anesth. 2016;30(1):200–16. https://doi.org/10.1053/j.jvca.2015.08.003.CrossRefPubMed

114.

Bessissow A, Khan J, Devereaux PJ, Alvarez-Garcia J, Alonso-Coello P. Postoperative atrial fibrillation in non-cardiac and cardiac surgery: an overview. J Thromb Haemost. 2015;13(Suppl 1):S304–12. https://doi.org/10.1111/jth.12974.CrossRefPubMed

115.

Polderman KH, Girbes AR. Severe electrolyte disorders following cardiac surgery: a prospective controlled observational study. Crit Care. 2004;8(6):R459–66. https://doi.org/10.1186/cc2973.CrossRefPubMedPubMedCentral

116.

Raiten JM, Ghadimi K, Augoustides JG, Ramakrishna H, Patel PA, Weiss SJ, et al. Atrial fibrillation after cardiac surgery: clinical update on mechanisms and prophylactic strategies. J Cardiothorac Vasc Anesth. 2015;29(3):806–16. https://doi.org/10.1053/j.jvca.2015.01.001.CrossRefPubMed

117.

Podrid PJ. Potassium and ventricular arrhythmias. Am J Cardiol. 1990;65(10):33E–44E discussion 52E.CrossRefPubMed

118.

Hoekstra M, Hessels L, Rienstra M, Yeh L, Lansink AO, Vogelzang M, et al. Computer-guided normal-low versus normal-high potassium control after cardiac surgery: no impact on atrial fibrillation or atrial flutter. Am Heart J. 2016;172:45–52. https://doi.org/10.1016/j.ahj.2015.10.020.CrossRefPubMed

119.

Gorenek Chair B, Pelliccia Co-Chair A, Benjamin EJ, Boriani G, Crijns HJ, Fogel RI, et al. European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS). Eur J Prev Cardiol. 2017;24(1):4–40. https://doi.org/10.1177/2047487316676037.CrossRef

120.

Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG, et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2011;58(24):e123–210. https://doi.org/10.1016/j.jacc.2011.08.009.CrossRefPubMed

121.

Sakamoto A, Kitakaze M, Takamoto S, Namiki A, Kasanuki H, Hosoda S. Landiolol, an ultra-short-acting beta(1)-blocker, more effectively terminates atrial fibrillation than diltiazem after open heart surgery: prospective, multicenter, randomized, open-label study (JL-KNIGHT study). Circ J. 2012;76(5):1097–101.CrossRefPubMed

122.

Hilleman DE, Hunter CB, Mohiuddin SM, Maciejewski S. Pharmacological management of atrial fibrillation following cardiac surgery. Am J Cardiovasc Drugs. 2005;5(6):361–9. https://doi.org/10.2165/00129784-200505060-00003.CrossRefPubMed

123.

January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64(21):e1–76. https://doi.org/10.1016/j.jacc.2014.03.022.CrossRefPubMed

124.

Freemantle N, Lafuente-Lafuente C, Mitchell S, Eckert L, Reynolds M. Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation. Europace. 2011;13(3):329–45. https://doi.org/10.1093/europace/euq450.CrossRefPubMed

125.

Milan DJ, Saul JP, Somberg JC, Molnar J. Efficacy of intravenous and oral sotalol in pharmacologic conversion of atrial fibrillation: a systematic review and meta-analysis. Cardiology. 2017;136(1):52–60. https://doi.org/10.1159/000447237.CrossRefPubMed

126.

Guerra F, Romandini A, Barbarossa A, Belardinelli L, Capucci A. Ranolazine for rhythm control in atrial fibrillation: a systematic review and meta-analysis. Int J Cardiol. 2017;227:284–91. https://doi.org/10.1016/j.ijcard.2016.11.103.CrossRefPubMed

127.

Mooss AN, Wurdeman RL, Mohiuddin SM, Reyes AP, Sugimoto JT, Scott W, et al. Esmolol versus diltiazem in the treatment of postoperative atrial fibrillation/atrial flutter after open heart surgery. Am Heart J. 2000;140(1):176–80. https://doi.org/10.1067/mhj.2000.106917.CrossRefPubMed

128.

Rezaei Y, Gholami-Fesharaki M, Dehghani MR, Arya A, Haghjoo M, Arjmand N. Statin Antiarrhythmic Effect on Atrial Fibrillation in Statin-Naive Patients Undergoing Cardiac Surgery: A Meta-Analysis of Randomized Controlled Trials. J Cardiovasc Pharmacol Ther. 2016;21(2):167–76. https://doi.org/10.1177/1074248415602557.CrossRefPubMed

129.

Faisal SA, Apatov DA, Ramakrishna H, Weiner MM. Levosimendan in Cardiac Surgery: Evaluating the Evidence. J Cardiothorac Vasc Anesth. 2018. https://doi.org/10.1053/j.jvca.2018.05.035.

130.

Abacilar AF, Dogan OF. Levosimendan use decreases atrial fibrillation in patients after coronary artery bypass grafting: a pilot study. Heart Surg Forum. 2013;16(5):E287–94.CrossRefPubMed

131.

Elbadawi A, Elgendy IY, Saad M, Megaly M, Mentias A, Abuzaid AS, et al. Meta-Analysis of Trials on Prophylactic Use of Levosimendan in Patients Undergoing Cardiac Surgery. Ann Thorac Surg. 2018;105(5):1403–10. https://doi.org/10.1016/j.athoracsur.2017.11.027.CrossRefPubMed

132.

Soleimani A, Habibi MR, Hasanzadeh Kiabi F, Alipour A, Habibi V, Azizi S, et al. The effect of intravenous N-acetylcysteine on prevention of atrial fibrillation after coronary artery bypass graft surgery: a double-blind, randomised, placebo-controlled trial. Kardiol Pol. 2018;76(1):99–106. https://doi.org/10.5603/KP.a2017.0183.CrossRefPubMed

133.

Mirmohammadsadeghi M, Mirmohammadsadeghi A, Mahmoudian M. Preventive Use of Ascorbic Acid For Atrial Fibrillation After Coronary Artery Bypass Graft Surgery. Heart Surg Forum. 2018;21(5):E415–E7. https://doi.org/10.1532/hsf.1938.CrossRefPubMed

134.

Rodrigo R, Korantzopoulos P, Cereceda M, Asenjo R, Zamorano J, Villalabeitia E, et al. A randomized controlled trial to prevent post-operative atrial fibrillation by antioxidant reinforcement. J Am Coll Cardiol. 2013;62(16):1457–65. https://doi.org/10.1016/j.jacc.2013.07.014.CrossRefPubMed

135.

Macle L, Cairns J, Leblanc K, Tsang T, Skanes A, Cox JL, et al. 2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation. Can J Cardiol. 2016;32(10):1170–85. https://doi.org/10.1016/j.cjca.2016.07.591.CrossRefPubMed

136.

Fan K, Lee KL, Chiu CS, Lee JW, He GW, Cheung D, et al. Effects of biatrial pacing in prevention of postoperative atrial fibrillation after coronary artery bypass surgery. Circulation. 2000;102(7):755–60.CrossRefPubMed

137.

Chung MK. Proarrhythmic effects of post-operative pacing intended to prevent atrial fibrillation: evidence from a clinical trial. Card Electrophysiol Rev. 2003;7(2):143–6.CrossRefPubMed

138.

Greenberg MD, Katz NM, Iuliano S, Tempesta BJ, Solomon AJ. Atrial pacing for the prevention of atrial fibrillation after cardiovascular surgery. J Am Coll Cardiol. 2000;35(6):1416–22.CrossRefPubMed

139.

Steinberg JS. Postoperative atrial fibrillation: a billion-dollar problem. J Am Coll Cardiol. 2004;6. United States:1001–3.CrossRef

140.

Mathew JP, Parks R, Savino JS, Friedman AS, Koch C, Mangano DT, et al. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group. Jama. 1996;276(4):300–6.CrossRefPubMed

141.

Pokushalov E, Romanov A, Cherniavsky A, Corbucci G, Pak I, Kareva Y, et al. Ablation of paroxysmal atrial fibrillation during coronary artery bypass grafting: 12 months' follow-up through implantable loop recorder. Eur J Cardiothorac Surg. 2011;40(2):405–11. https://doi.org/10.1016/j.ejcts.2010.11.083.CrossRefPubMed

142.

Cherniavsky A, Kareva Y, Pak I, Rakhmonov S, Pokushalov E, Romanov A, et al. Assessment of results of surgical treatment for persistent atrial fibrillation during coronary artery bypass grafting using implantable loop recorders. Interact Cardiovasc Thorac Surg. 2014;18(6):727–31. https://doi.org/10.1093/icvts/ivu016.CrossRefPubMed

143.

Pokushalov E, Romanov A, Corbucci G, Cherniavsky A, Karaskov A. Benefit of ablation of first diagnosed paroxysmal atrial fibrillation during coronary artery bypass grafting: a pilot study. Eur J Cardiothorac Surg. 2012;41(3):556–60. https://doi.org/10.1093/ejcts/ezr101.CrossRefPubMed

144.

Blomstrom-Lundqvist C, Johansson B, Berglin E, Nilsson L, Jensen SM, Thelin S, et al. A randomized double-blind study of epicardial left atrial cryoablation for permanent atrial fibrillation in patients undergoing mitral valve surgery: the SWEDish Multicentre Atrial Fibrillation study (SWEDMAF). Eur Heart J. 2007;28(23):2902–8. https://doi.org/10.1093/eurheartj/ehm378.CrossRefPubMed

145.

Bagge L, Probst J, Jensen SM, Blomstrom P, Thelin S, Holmgren A, et al. Quality of life is not improved after mitral valve surgery combined with epicardial left atrial cryoablation as compared with mitral valve surgery alone: a substudy of the double blind randomized SWEDish Multicentre Atrial Fibrillation study (SWEDMAF). Europace. 2017. https://doi.org/10.1093/europace/eux253.

146.

Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35(37):2541–619. https://doi.org/10.1093/eurheartj/ehu278.CrossRefPubMed

147.

Shaefi S, Mittel A, Loberman D, Ramakrishna H. Off-Pump Versus On-Pump Coronary Artery Bypass Grafting-A Systematic Review and Analysis of Clinical Outcomes. J Cardiothorac Vasc Anesth. 2018. https://doi.org/10.1053/j.jvca.2018.04.012.

148.

Almassi GH, Pecsi SA, Collins JF, Shroyer AL, Zenati MA, Grover FL. Predictors and impact of postoperative atrial fibrillation on patients' outcomes: a report from the Randomized On Versus Off Bypass trial. J Thorac Cardiovasc Surg. 2012;143(1):93–102. https://doi.org/10.1016/j.jtcvs.2011.10.003.CrossRefPubMed

149.

Lee JK, Klein GJ, Krahn AD, Yee R, Zarnke K, Simpson C, et al. Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study. Am Heart J. 2000;140(6):871–7. https://doi.org/10.1067/mhj.2000.111104.CrossRefPubMed

150.

Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg. 2016;50(5):e1–e88. https://doi.org/10.1093/ejcts/ezw313.CrossRefPubMed

151.

Gillinov AM, Bagiella E, Moskowitz AJ, Raiten JM, Groh MA, Bowdish ME, et al. Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery. N Engl J Med. 2016;374(20):1911–21. https://doi.org/10.1056/NEJMoa1602002.CrossRefPubMedPubMedCentral

152.

Afifi A. CTS trials network: Rate control vs rhythm control for atrial fibrillation after cardiac surgery - Do bitter pills have blessed effects? Glob Cardiol Sci Pract. 2016;2016(2):e201615. https://doi.org/10.21542/gcsp.2016.15.CrossRefPubMedPubMedCentral

153.

Tisdale JE, Padhi ID, Goldberg AD, Silverman NA, Webb CR, Higgins RS, et al. A randomized, double-blind comparison of intravenous diltiazem and digoxin for atrial fibrillation after coronary artery bypass surgery. Am Heart J. 1998;135(5 Pt 1):739–47.CrossRefPubMed

154.

Oral H, Souza JJ, Michaud GF, Knight BP, Goyal R, Strickberger SA, et al. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. N Engl J Med. 1999;340(24):1849–54. https://doi.org/10.1056/nejm199906173402401.CrossRefPubMed

155.

Kowey PR, Dorian P, Mitchell LB, Pratt CM, Roy D, Schwartz PJ, et al. Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial. Circ Arrhythm Electrophysiol. 2009;2(6):652–9. https://doi.org/10.1161/circep.109.870204.CrossRefPubMed

156.

Roy D, Pratt CM, Torp-Pedersen C, Wyse DG, Toft E, Juul-Moller S, et al. Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial. Circulation. 2008;117(12):1518–25. https://doi.org/10.1161/circulationaha.107.723866.CrossRefPubMed

157.

Pratt CM, Roy D, Torp-Pedersen C, Wyse DG, Toft E, Juul-Moller S, et al. Usefulness of vernakalant hydrochloride injection for rapid conversion of atrial fibrillation. Am J Cardiol. 2010;106(9):1277–83. https://doi.org/10.1016/j.amjcard.2010.06.054.CrossRefPubMed

158.

Camm AJ, Capucci A, Hohnloser SH, Torp-Pedersen C, Van Gelder IC, Mangal B, et al. A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation. J Am Coll Cardiol. 2011;57(3):313–21. https://doi.org/10.1016/j.jacc.2010.07.046.CrossRefPubMed

159.

Dalyanoglu H, Mehdiani A, Minol JP, Sipahi NF, Aubin H, Boeken U, et al. Conversion of atrial fibrillation after cardiosurgical procedures by vernakalant(R) as an atrial repolarization delaying agent (ARDA). Heart Surg Forum. 2018;21(3):E201–e8. https://doi.org/10.1532/hsf.1970.CrossRefPubMed

160.

Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. Jama. 2001;285(22):2864–70.CrossRefPubMed

161.

Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010;138(5):1093–100. https://doi.org/10.1378/chest.10-0134.CrossRefPubMed

162.

Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, et al. A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol. 2011;58(4):395–401. https://doi.org/10.1016/j.jacc.2011.03.031.CrossRefPubMedPubMedCentral

163.

Gage BF, Yan Y, Milligan PE, Waterman AD, Culverhouse R, Rich MW, et al. Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J. 2006;151(3):713–9. https://doi.org/10.1016/j.ahj.2005.04.017.CrossRefPubMed

164.

Peguero JG, Issa O, Podesta C, Elmahdy HM, Santana O, Lamas GA. Usefulness of the CHA2DS2VASc score to predict postoperative stroke in patients having cardiac surgery independent of atrial fibrillation. Am J Cardiol. 2015;115(6):758–62. https://doi.org/10.1016/j.amjcard.2014.12.037.CrossRefPubMed

165.

Bosch NA, Cimini J, Walkey AJ. Atrial fibrillation in the ICU. Chest. 2018;154(6):1424–34. https://doi.org/10.1016/j.chest.2018.03.040.CrossRefPubMedPubMedCentral

166.

Manning WJ, Silverman DI, Keighley CS, Oettgen P, Douglas PS. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study. J Am Coll Cardiol. 1995;25(6):1354–61. https://doi.org/10.1016/0735-1097(94)00560-d.CrossRefPubMed

167.

Jaber WA, Prior DL, Thamilarasan M, Grimm RA, Thomas JD, Klein AL, et al. Efficacy of anticoagulation in resolving left atrial and left atrial appendage thrombi: A transesophageal echocardiographic study. Am Heart J. 2000;140(1):150–6. https://doi.org/10.1067/mhj.2000.106648.CrossRefPubMed

168.

Sessler DI. Lost in translation: the 2016 John W Severinghaus lecture on translational research. Anesthesiology. 2017;126(6):995–1004. https://doi.org/10.1097/ALN.0000000000001603.CrossRefPubMed

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

New-Onset Atrial Fibrillation in Adult Patients After Cardiac Surgery

Abstract

Purpose of Review

Recent Findings

Summary

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 2/2019

Stage 1 Palliation of Hypoplastic Left Heart Syndrome: What the Pediatric Anesthesiologist Needs to Know

Perioperative Oxygenation Targets in Adults

Pharmacologic Treatment of Insomnia in Children and Adolescents with Chronic Pain Conditions

Fluid Management in Septic Shock: a Review of Physiology, Goal-Directed Therapy, Fluid Dose, and Selection

Renal Replacement Therapy in Critical Care: When to Start?

Current Concepts in the Management of the Difficult Pediatric Airway